# Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis

> **NCT04665596** · NA · COMPLETED · sponsor: **Cardiawave SA** · enrollment: 10 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** Ultrasound treatment

## Key facts

- **NCT ID:** NCT04665596
- **Lead sponsor:** Cardiawave SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-23
- **Primary completion:** 2022-06-15
- **Final completion:** 2024-05-23
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04665596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04665596, "Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04665596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*